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Background & objectives: Cytokine gene polymorphisms may alter Th1/Th2 balance with major
implications in tuberculosis. The aim of our study was to find out whether Interferon  +874A and
IL-4 -590T polymorphisms were associated with susceptibility to pulmonary tuberculosis as well
as the level of IFN and IL-4 in south Indian population.
Methods: Interferon  +874A and IL-4 -590T promoter polymorphisms were studied in 129
pulmonary tuberculosis (PTB) patients and 127 normal healthy subjects (NHS) and were associated
with culture filtrate and live Mycobacterium tuberculosis induced IFN and IL-4 production in
peripheral blood mononuclear cells (PBMCs). IL-4 gene variants were also associated with IgG
antibody levels against M. tuberculosis culture filtrate antigen.
Results: The variant IFN genotypes and IFN levels between genotypes did not differ significantly
in patients and controls. Significantly increased frequency of variant IL-4 ‘CT’ genotype in PTB
patients (P<0.05) and ‘CC’ genotype in control group (P<0.01) was observed. IL-4 levels were
detectable in very few subjects and the IgG levels did not differ between the three IL-4 genotypes.
Interpretation & conclusion: The study suggests a lack of functional association of Interferon 
+874A polymorphism in tuberculosis in south Indian population. The higher frequency of IL-4
‘CT’ genotype in PTB suggests a possible association of IL-4 -590T promoter polymorphism with
susceptibility to tuberculosis, and the ‘CC’ genotype may be associated with protection.
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Mycobacterium tuberculosis is a successful
intracellular pathogen that can persist in the human
host in the face of a robust immune response.  Attempts
have been made to identify the host genes associated
with tuberculosis susceptibility to understand the host
pathogen interaction. Various studies relating cytokine
production with tuberculosis disease progression have
shown that a preferential production of Interferon 
(IFN-) occurs in mild disease whereas in advanced
stages, the level of Interleukin -4 (IL-4) increases with
a concomitant decrease in IFN production1.  Such a
shift in balance between Th1 and Th2 cytokines may be
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disrupted by polymorphisms in the cytokine genes and
this may decide the disease outcome and progression.
Interferon , a Th1 type of cytokine is important
in the initial protective immune response against
Mycobacterium tuberculosis infection. Individuals
defective in the genes for IFN or IFN receptor have
been shown to be prone for mycobacterial infections
including M. tuberculosis2. Inter-individualistic
differences have been seen in the production of IFN
and some studies have shown a depressed production
of IFN in active tuberculosis3,4.  An earlier study has
reported a significant functional association of IFN
+ 874 A/T polymorphism with development of
tuberculosis in a Spanish population5.
Interleukin-4, a Th2 type of cytokine is generally
elevated in advanced stages of tuberculosis and
downregulates protective Th1 responses6. In progressive
disease it causes increased rather than diminished
immuno-pathology7. A single nucleotide polymorphism
in the IL-4 promoter region represents a C to T transition
589 base pairs upstream of the transcription start site.
This polymorphism has been shown to be associated
with enhanced promoter strength and increased binding
of nuclear transcription factors to the promoter and also
with different levels of IL-4 activity8 and increased IgG
levels against specific antigens9.
In the present study, we have investigated the
association of single nucleotide polymorphisms in the
intronic region of Interferon   (+874 A) gene and
promoter region of IL-4 gene (-590T) to study the
influence of these polymorphisms in tuberculosis
susceptibility in a south Indian population. The
genotypes were further associated with the levels of
IFN and IL-4 produced spontaneously and upon
antigen stimulation in vitro to assess the influence of
these polymorphisms on cytokine production.
Material & Methods
Study subjects: The study group included 129
pulmonary tuberculosis (PTB) patients (mean age ±
SD: 36 ± 12.3 yr) and 127 normal healthy subjects
(mean age ± SD: 30 ± 9.2 yr). Patients attending
Tuberculosis Research Centre, (TRC) Chennai from
January 2004 to December 2005, with respiratory
symptoms and radiographic abnormalities
suggestive of PTB and sputum positive for
M. tuberculosis by both smear and culture were
included. All the patients were in the initial stages
of the disease. Among the 129 patients, 74 were
males (mean age ± SD: 39 ± 12 yr) and 55 females
(mean age ± SD: 32 ± 11.3 yr). Blood samples were
collected after informed consent was obtained and
before starting chemotherapy. The study had been
approved by the ethical committee of the institute.
Normal healthy subjects (NHS) were volunteers
who were clinically normal at the time of blood
collection. The NHS group comprised 74 males
(mean age ± SD: 32 ± 8.5 yr) and 53 females (mean
age ± SD: 27 ± 9.4 yr). All the patients and normals
were south Indians and belonged to the same ethnic
origin.
Peripheral blood mononuclear cell (PBMC)
separation: Twenty milliliters of venous blood was
collected, defibrinated and the PBMC were separated
by Ficoll - Hypaque density gradient centrifugation10.
Cell viability was checked using trypan blue dye
exclusion and the PBMCs were used for cytokine
culture and DNA extraction.
In vitro cytokine production: PBMCs were cultured
in sterile 48 well tissue culture plates (Costar,
Cambridge, MA, USA) at a concentration of 2 million
cells/ml in Rosewell Park Memorial Institute (RPMI)
medium supplemented with 2 per cent autologous
serum for 72 h at 37°C and 5 per cent CO2. The
cultures were stimulated with live M. tuberculosis
H37Rv, culture filtrate antigen (CFA) of
M. tuberculosis (10 µg/ml) and phytohaemagglutinin
(PHA) (Sigma, St. Louis, USA) (1 µg/ml). The
culture supernatants were harvested at the end of
72 h and stored at -80°C until use. IL-4 and IFN
levels were estimated in the supernatants using
commercially available ELISA kits (R&D Systems,
Minneapolis, MN, USA).
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DNA extraction: DNA was extracted from a portion
of lymphocytes by a salting out procedure as
described earlier11. The concentration and purity of
DNA was estimated spectrophotometrically.
Genotyping: IFN genotyping was done by using
amplification refractory mutation system-polymerase
chain reaction (PCR) method as described before 5,12.
DNA was amplified in two different PCR reactions
with a generic antisense primer (5’-
TCAACAAAGCTGATACTCCA-3’) and one
of the two allele specific sense primers [Primer A
(sense) 5’ TTCTTACAACACAAAATCAAATCA-3’
and Primer T (sense) 5’-
TTCTTACAACACAAAATCAAATCT-3’].  The
PCR reaction conditions were 10 cycles (95°C for 1
minute, 95°C for 15 seconds, 62°C for 50 seconds,
and 72°C for 40 seconds), followed by 20 cycles (95°C
for 20 seconds, 56°C for 50 seconds, and 72°C for 50
seconds).  To check for the success of PCR
amplification an internal control of 426 bp was
amplified using a pair of primers designed
from the nucleotide sequence of human growth
hormone.  The primer sequences for internal
control were Primer 1 (sense) 5’-
CCTTCCAACCATTCCCTTA-3’ and Primer 2
(antisense) 5’-TCACGGATTTCTGTTGTGTTTC-3’.
IL-4 genotyping was performed as described
earlier13. Briefly, PCR reaction was performed with
specific primers and the reaction conditions were
95°C for 3 min, followed by 30 cycles of 95°C
for 30 sec, 57°C for 30 sec, and 72°C for 1 min.
The primers amplified nucleotide sequences of
-680 to -491. The forward primer sequence
was 5,-GTAAGGACCTTATGGACCTGC-3’
and the reverse primer sequence was 5’-
CATCTTGGAAACTGTCCTGTC-3’. The PCR
products were denatured and blotted onto nytran
membranes. Genotyping was performed using
sequence-specific oligonucleotide probing
(SSOP) with eighteen-mer  oligonucleotide
probes with the sequence IL-4-590T,
5’-GAACATTGTTCCCCAGTG-3’,; IL-4-590C,
5’-GAACATTGTCCCCCAGTG-3’.
IgG antibody estimation: The optical density (O.D.)
value at 490 nm of IgG antibody (1:100, 1:500 and
1:1000 dilutions) against M. tuberculosis H37Rv
culture filtrate antigen (5 µg/ml) was estimated in
the serum samples by enzyme linked immunosorbent
assay (ELISA).
Statistical analysis: Genotype frequencies of IL-4
and IFN genes were estimated by direct genotypic
counts and expressed as percentage. Comparison
between patients and controls was done using 2x2
contingency tables and 2 test with Yates correction
(Stat calc programme, Epi Info Version 6.04, CDC,
Atlanta, GA, USA). The frequencies were also tested
Table. Variant allele and genotype frequencies of IFN  (+874A) and IL-4 (-590T) gene in normal healthy subjects (NHS) and
pulmonary tuberculosis (PTB) patients
IFN and IL-4 Allele frequencies Genotypes Genotype frequency (%)
polymorphisms
NHS (n=127) PTB(n=129) NHS (n=127) PTB (n=129)
IFN  (+874 T/A) A - 0.64 0.68 AA 43.3 (55) 47.2 (61)
T - 0.36 0.36 AT 40.9 (52) 41.9 (54)
TT 15.8 (20) 10.9 (14)
IL-4 (-590T ) C - 0.89 0.79 CC 80.3 (102)* 64.3 (83)
T- 0.11 0.21 CT 16.5 (21) 31 (40)**
TT 3.2 (4) 4.7 (6)
*P=0.006, **P=0.01
IFN - AA, homozygotes of allele ‘A’; TT, homozygotes allele ‘T’; AT, heterozygotes of alleles ‘A’ & ‘T’
IL-4 - CC, homozygotes of allele ‘C’; TT, homozygotes of allele ‘T’; CT, heterozygotes of allele ‘C’ & ‘T’
for Hardy-Weinberg equilibrium by calculating allele
frequencies using Pearson’s  2 test with one degree
of freedom.  Results of cytokine and antibody assays
were expressed as arithmetic mean + SE and analyzed
by student’s t test. P<0.05 was considered
statistically significant.
Results
The frequencies of the three IFN genotypes (AA,
AT and TT) and the allele frequencies did not differ
significantly between the PTB and NHS group. All
the three genotypes conformed to Hardy Weinberg
equilibrium (Table).
The spontaneous and induced IFN levels were
significantly higher in NHS when compared to
PTB patients (Cells, P<0.05; CFA, PHA, M.
tuberculosis P<0.001) (Fig. 1). No significant
difference was observed in IFN levels between
the three IFN genotypes of PTB and NHS groups
(Fig. 2).
Fig. 1. Spontaneous and induced production of Interferon
(IFN) by peripheral blood mononuclear cells (PBMC) in vitro,
in normal healthy subjects (NHS) and pulmonary tuberculosis
(PTB) patients. Peripheral blood mononuclear cells were
cultured for 72 h to determine spontaneous IFN release or
stimulated with phytohaemagglutinin (PHA), culture filtrate
antigen (CFA) or live M. tuberculosis to estimate the antigen
specific IFN  release. Results are expressed as mean
+ standard error (SE). Number of subjects studied in each group:
NHS=59 and PTB=60. P*<0.05, **<0.001 compared to NHS.
Fig. 2. Variant IFN genotypes and IFN production in NHS and PTB. PBMCs were cultured for 72 h to determine spontaneous IFN
release or stimulated with phytohaemagglutinin (PHA), culture filtrate antigen (CFA) or live M. tuberculosis to estimate the
antigen induced IFN release. Results are expressed as mean + SE. Numbers in parentheses represent the number of subjects studied
in each group.
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Among the three variant IL-4 genotypes, the
frequency of heterozygous genotype ‘CT’ was
significantly higher in PTB patients than controls
(P<0.05, odds ratio (OR) 2.3; 95% confidence
interval, 1.2-4.32).  Significantly higher frequencies
of the genotype ‘CC’ were observed in controls
(P<0.01, OR-0.44; 95% confidence interval, 0.24-
0.81) when compared to patients.  The homozygous
genotype ‘TT’ for the rarer allele ‘T’ was low in
numbers and did not differ much in the frequencies
between the two groups. All the 3 genotypes
conformed to Hardy-Weinberg equilibrium. The
frequency of the ‘C’ allele of IL-4 was 0.79 and 0.89
and that of ‘T’ allele was 0.21 and 0.11 in patients
and controls respectively. When the allele
frequencies were compared, the frequency of allele
‘T’ was significantly higher in patients and that of
allele ‘C’ was significantly higher in the control
group (P<0.01) (Table).
The IL-4 levels were low or undetectable in the
culture supernatants in most of the patients and control
subjects. Nearly, 15-20 per cent of NHS and PTB
patients were IL-4 producers to various stimulations.
Individuals with variant IL-4 genotypes did not vary
significantly in their IL-4 production (Fig. 3).
The IgG antibody levels against M. tuberculosis
H37Rv CFA was significantly higher in patients
(P<0.001) when compared to normals.  Among the
three variant IL-4 genotypes, no difference in the IgG
antibody levels was observed in both patients and
controls (Fig. 4).
Discussion
In the present study, single nucleotide
polymorphisms in the IFN and IL-4 genes were
associated with in vitro cytokine production in
pulmonary tuberculosis patients and normal healthy
subjects. There was no significant difference in the
frequency of IFN genotypes between NHS and PTB,
showing a lack of association of IFN (+874 T/A)
polymorphism with tuberculosis susceptibility.
The spontaneous, mitogen and antigen induced
IFN production was significantly higher in NHS
when compared to patients. A decreased IFN
production has been reported earlier in tuberculosis
patients3,4 and it may be due to the initial T cell anergy
seen in the disease. Such an inadequate IFN
Fig. 3. IL-4 levels in NHS and PTB patients with variant IL-4
genotypes. PBMCs were cultured either with or without the
mitogen and the antigens for 72 h and IL-4 level was estimated
in the supernatants by ELISA. This graph represents the results
only in few subjects where the levels were detectable. Number
of subjects responded/total number of subjects studied for
cytokine levels in each group: NHS: CC-11/68, CT-4/17 and
TT-1/4; PTB: CC -8/44, CT-5/20 and TT-1/3.
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production may result in failure of macrophage
activation, which could lead to active disease
progression. When the IFN levels were compared
between the IFN  genotypes, no significant
difference could be found. On the other hand, a study
by Lo´pez-Maderuelo et al5 has revealed a functional
association between the IFN- (+874 A/T)
polymorphism and development of pulmonary
tuberculosis in Spanish whites. In their study, patients
with tuberculosis and tuberculin-reactive contacts
that were homozygous for the IFN 874A allele were
shown to produce significantly less IFN- than those
with other allele combinations. Our results did not
match with these findings and this may be due to
ethnic differences in genotypic frequencies among
various populations. Functional variants in the
closely linked alleles of IFN gene may also influence
the cytokine production and need to be studied.
There is substantial evidence that an IL-4 response
in tuberculosis downregulates protective Th1 responses.
A study by Wangoo et al demonstrated that a pre-
existing Th2 response was sufficient to undermine the
efficacy of the dominant Th1 response14. IL-4 can
downregulate inducible nitric oxide synthase (iNOS),
Toll-like receptor 2 (TLR2) and macrophage activation
and this may determine whether the infection becomes
latent or progressive15-17.
A single nucleotide polymorphism at position
-590 in the IL-4 promoter region has been shown to
be associated with enhanced IL-4 promoter strength
and altered IL-4 activity and production9. Such a
functional polymorphism in the IL-4 gene may alter
IL-4 levels and thereby influence the IL-4 dependent
events which determine disease progression. Based
on this hypothesis, we investigated the association
and functional significance of the IL-4 -590
polymorphism in pulmonary tuberculosis.
In the present study, the genotype frequency of
the heterozygous ‘CT’ genotype of IL-4 gene was
Fig. 4. The optical density (OD) values at 490 nm of IgG antibody at 1 : 1000 serum dilution against M. tuberculosis H37Rv culture
filtrate antigen in NHS and PTB patients with variant IL-4 gene variants. The levels were also measured at 1:100 and 1:500 dilutions,
but no significant difference was observed between the three genotypes in any of the given dilution. Number of subjects studied in
each group: NHS: CC-53, CT-10 and TT-3; PTB: CC -27, CT-16 and TT-1.
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significantly higher in patients with a 2.3 fold risk,
whereas the homozygous ‘CC’ genotype showed
significantly higher frequency in the NHS group.
Similarly, higher frequencies were found for the ‘T’
allele in PTB and the ‘C’ allele in NHS suggesting
that ‘T’ allele may be associated with susceptibility
and the ‘C’ allele with resistance to tuberculosis. It
has been shown in an earlier study that the ‘T’ allele
is associated with delayed acquisition of X4 variants
but not disease progression in HIV patients18.
An increased binding of transcription factors
has been shown with IL-4 -590 T polymorphism8.
This may alter the gene expression and have
funct ional  effects  on the rate  of  cytokine
production which in turn could influence disease
susceptibility.
In view of this concept, we tried to associate the
IL-4 genotypes with IL-4 production in vitro, but very
few subjects responded by producing detectable
levels of IL-4. The overall low IL-4 levels may be
due to the low concentrations and low mRNA copy
numbers at which IL-4 is active19 or may be due to a
downregulation of Th2 cell proliferation because of
the Interferon   secreted on stimulation with
mycobacterial antigens.
Since IL-4 is involved in B cell proliferation
and antibody production, IgG antibody levels to
CFA was measured in the serum samples. The levels
were higher in patients as expected, but there was
not much difference between the three IL-4
genotypes studied.
In conclusion, the present study suggests a
possible association of the IL-4 -590T promoter
polymorphism with susceptibility to pulmonary
tuberculosis. However, no association of IL-4
genotypes with IL-4 levels was seen. Interferon 
gene (+874 T/A) polymorphism neither associated
with tuberculosis susceptibility nor with IFN
secretion. A similar approach with other cytokine
genes may elucidate the regulatory role played by
these genes in immunity to tuberculosis.
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